Health and Fitness Health and Fitness
Wed, February 11, 2009
[ Wed, Feb 11th 2009 ] - Market Wire
Angeion to Announce 2009 First-Quarter Results on Wednesday, February 25
[ Wed, Feb 11th 2009 ] - Market Wire
Synta Pharmaceuticals to Present at the ROTH Capi .. l Partners 21st Annual OC Growth Stock Conference
[ Wed, Feb 11th 2009 ] - Market Wire
Orthofix International and The Musculoskeletal Tr .. Accelerate Release Date for Trinity® Evolution"
[ Wed, Feb 11th 2009 ] - Market Wire
Genta Submits Randomized Study of Tesetaxel in Pa .. ric Cancer to FDA for Special Protocol Assessment
[ Wed, Feb 11th 2009 ] - Market Wire
POZEN Announces February 25, 2009 Webcast of Fourth Quarter and Year End 2008 Results
[ Wed, Feb 11th 2009 ] - Market Wire
Halozyme to Present at Roth Capital Growth Conference
[ Wed, Feb 11th 2009 ] - Market Wire
Professor John F. Thompson to Present at the Sixt .. Melanoma and Other Cutaneous Malignancies on Marc
[ Wed, Feb 11th 2009 ] - Market Wire
Alnylam and Collaborators Publish New Pre-Clinica .. ivo Efficacy of Systemically Delivered RNAi Thera
[ Wed, Feb 11th 2009 ] - Market Wire
Compugen Ltd. Reports Fourth Quarter and Year-End 2008 Financial Results
[ Wed, Feb 11th 2009 ] - Market Wire
Salix Pharmaceuticals to Present at Roth Conference
[ Wed, Feb 11th 2009 ] - Market Wire
Gilead pr©sente des donn©es montrant l?activit© d?amplification pharmacocin©tique du GS 9350
[ Wed, Feb 11th 2009 ] - Market Wire
Zacks Industry Outlook Highlights: Pfizer, Eli Lilly, Merck, Sanofi and Schering-Plough
[ Wed, Feb 11th 2009 ] - Market Wire
Micrus Endovascular Initiates VISSIT Trial with Pharos Vitesse Balloon Expandable Stent
Tue, February 10, 2009
[ Tue, Feb 10th 2009 ] - Market Wire
SCOR: SCOR records strong 2009 Non-Life renewals .. ith a view to greater profitability and predictab
[ Tue, Feb 10th 2009 ] - Market Wire
Edwards Lifesciences: Edwards Lifesciences Receiv .. Transfemoral Transcatheter Valve Delivery System
[ Tue, Feb 10th 2009 ] - Market Wire
FDA Issues Complete Response Letter for RISPERDAL .. unctive Maintenance Treatment of Bipolar Disorder
[ Tue, Feb 10th 2009 ] - Market Wire
Cytokinetics, Inc.: Cytokinetics, Incorporated Re .. ourth Quarter and Year End 2008 Financial Results
[ Tue, Feb 10th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Closes Pr .. opian Potash Acquisition and Grants Stock Options
[ Tue, Feb 10th 2009 ] - Market Wire
Conceptus® to Introduce 2009 Guidance and Hold F .. nancial Results Conference Call February 17, 2009
[ Tue, Feb 10th 2009 ] - Market Wire
Alkermes? Corporate Presentation to be Webcast at the 21st Annual Roth OC Growth Stock Conference
[ Tue, Feb 10th 2009 ] - Market Wire
America Service Group Announces Contract for Pris .. h the State of Michigan Department of Corrections
[ Tue, Feb 10th 2009 ] - Market Wire
Proteonomix, Inc.: Proteonomix, Inc. (PROT) Annou .. Sale of Its Stem Cell Derived Cosmeceutical Prod
[ Tue, Feb 10th 2009 ] - Market Wire
Neoprobe Hires V.P. of Pharmaceutical Research & Clinical Development
[ Tue, Feb 10th 2009 ] - Market Wire
Resumen: Gilead presenta datos que demuestran el efecto farmacoquin©tico reforzador de GS 9350
[ Tue, Feb 10th 2009 ] - Market Wire
Endologix?s New IntuiTrak Endovascular AAA System Featured at International Congress
[ Tue, Feb 10th 2009 ] - Market Wire
Humana To Open National Health Care Center In St. Petersburg
[ Tue, Feb 10th 2009 ] - Market Wire
Teva Announces Approval and Launch of Generic Imitrex® Tablets
[ Tue, Feb 10th 2009 ] - Market Wire
Daxor Corp.: Daxor Announces Publication in The A .. oncerning Blood Volume in Critically Ill Surgical
[ Tue, Feb 10th 2009 ] - Market Wire
Significant Shareholder Calls upon Enzon to Immed .. tely Add Two Candidates to the Board of Directors
[ Tue, Feb 10th 2009 ] - Market Wire
Medtronic to Announce Financial Results for Its Third Fiscal Quarter

Medtronic to Announce Financial Results for Its Third Fiscal Quarter


Published on 2009-02-10 07:09:57, Last Modified on 2009-02-10 07:10:24 - Market Wire
  Print publication without navigation


MINNEAPOLIS--([ BUSINESS WIRE ])--Medtronic, Inc. (NYSE: MDT), announced today it will report financial results for its third fiscal quarter on Tuesday, February 17, 2009. A news release will be issued at approximately 6:15 a.m. Central Standard Time and will be available at [ www.medtronic.com/newsroom ]. The earnings news release will include summary financial information for Medtronic's third fiscal quarter ended January 23, 2009.

Medtronic will host a webcast at 7 a.m. Central Standard Time to discuss financial results for its third fiscal quarter. The webcast can be accessed by clicking on the Investor Relations link through the Medtronic Web site at [ www.medtronic.com ].

Within 24 hours of the webcast, a replay, a podcast and a transcript of the prepared remarks will be available under the Events and Presentations page in the Investor Relations section of the Medtronic Web site.

About Medtronic

Medtronic, Inc. ([ www.medtronic.com ]), headquartered in Minneapolis, is the world's leading medical technology company, alleviating pain, restoring health, and extending life for people with chronic disease.

Contributing Sources